In proof-of-concept studies, NNMT inhibitors (NNMTis) have demonstrated promise as potential treatments for obesity and obesity-related metabolic comorbidities (e.g., T2D, fatty liver) 8,9,13
Tratti distintivi che ci caratterizzano e che ci poniamo di perseguire costantemente sono affidabilit, flessibilit, cooperazione
Molecular Structure The amino acid sequence of BPC 157 is: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val This peptide is chemically stable, making BPC 157 resistant to enzymatic degradation
Not appropriate during pregnancy or breastfeeding BPC-157 is not used during pregnancy or breastfeeding
With our focus on excellent customer service and reliable, discreet shipping, you can feel confident in your decision to partner with IsraelPharm for your health and wellness journey